A team of scientists has challenged long-held assumptions about how immune recognition works, discovering that lipid molecules can be displayed to T cells in a sideways orientation. This new model allows for more flexibility in the immune system's ability to survey its environment and respond to threats.
SourceMonash University·JournalNature Communications·DateJan 15, 2026
Researchers have identified a new immune function of human M cells, which can process and present gluten antigens, suggesting a potential link to celiac disease. This discovery sheds light on gut immunity and may support future research into celiac disease diagnosis or treatment.
SourceHubrecht Institute·JournalNature·TypeExperimental study·DateDec 10, 2025
Scientists at the Institute for Systems Biology have discovered how T cells respond to infections like COVID-19, revealing a predictable pattern based on genetic interactions. This breakthrough could lead to improved treatments and vaccine strategies for diseases such as cancer and autoimmune disorders.
SourceInstitute for Systems Biology·JournalNature Communications·DateFeb 9, 2025
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Researchers found that neoself-antigens, presented on MHC-II, induce an immune response and lead to autoimmunity in lupus patients. EBV reactivation increases the presentation of these antigens, triggering T cell activation and autoimmune disease development.
SourceImmunology Frontier Research Center (IFReC) - Osaka University·JournalCell·TypeExperimental study·DateSep 13, 2024
A recent study has elucidated the genetic factors involved in systemic lupus erythematosus (SLE) development. The researchers found that HLA-DRB1*15:01 is primarily associated with SLE development in the Japanese population, suggesting its role in influencing disease progression. Furthermore, the study highlights the importance of anal...
SourceUniversity of Tsukuba·JournalRMD Open·DateJul 4, 2023
A new study found that the antibody-drug conjugate STRO-001 showed nanomolar cytotoxicity in 88% of cancer cell lines tested, with potent efficacy against proliferating B cells. The research supports ongoing clinical studies for patients with B-cell non-Hodgkin lymphoma.
SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateJan 17, 2023
Researchers from Nara Institute of Science and Technology found that alveolar macrophages act as antigen-presenting cells to prime CD8+ T cell expansion in the lungs. This process involves the production of interleukin 18, leading to the development of resident memory-type cell populations.
SourceNara Institute of Science and Technology·JournalCell Reports·DateDec 27, 2022